SYK Intrinsic Value

Intrinsic Value of SYK Overview

Key Highlights:
As of Mar 21, 2025 SYK Relative Value is $304.9, which is overvalued by 17.8%, compared to current share price of $371.1.
As of Mar 21, 2025 SYK DCF Value is $307.0, which is overvalued by 17.3%, compared to current share price of $371.1.
Methodology
Price per share, $
Current share price
371.1

SYK Historical Intrinsic Value

Crunching data... Almost there!
Crunching data... Almost there!

SYK Valuation Metrics

LTM
NTM
1Y Forward
2Y Forward
EV/Revenue
6.7x (as of Mar 21, 2025)
EV/Gross Profit
10.6x (as of Mar 21, 2025)
EV/EBIT
39.6x (as of Mar 21, 2025)
EV/EBITDA
26.3x (as of Mar 21, 2025)
EV/FCF
43.2x (as of Mar 21, 2025)
EV/OCF
35.5x (as of Mar 21, 2025)
P/Revenue
6.3x (as of Mar 21, 2025)
P/Gross Profit
10.0x (as of Mar 21, 2025)
P/EBIT
37.2x (as of Mar 21, 2025)
P/EBITDA
24.7x (as of Mar 21, 2025)
P/FCF
40.5x (as of Mar 21, 2025)
P/OCF
33.3x (as of Mar 21, 2025)
P/E
47.2x (as of Mar 21, 2025)
P/BV
6.9x (as of Mar 21, 2025)
PEG 1Y
0.7x (as of Mar 21, 2025)

SYK DCF Model

Free Cash Flow to Firm Model
NOPAT Model
Free Cash Flow to Equity Model
Net Income Model
Millions
Billions
Dec'20 ActualDec'21 ActualDec'22 ActualDec'23 ActualDec'24 ActualDec'25 EstimateDec'26 EstimateDec'27 EstimateDec'28 EstimateDec'29 EstimateDec'30 EstimateDec'31 EstimateDec'32 EstimateDec'33 EstimateDec'34 EstimateDec'35 Terminal
% growth
14,351.0
(3.6%)
17,108.0
19.2%
18,449.0
7.8%
20,498.0
11.1%
22,595.0
10.2%
24,510.0
8.5%
26,400.9
7.7%
28,651.0
8.5%
31,088.0
8.5%
33,426.0
7.5%
35,688.0
6.8%
37,834.2
6.0%
39,824.4
5.3%
41,619.2
4.5%
43,181.3
3.8%
44,476.8
3.0%
2,223.0
15.5%
2,584.0
15.1%
2,841.0
15.4%
3,888.0
19.0%
3,689.0
16.3%
4,939.3
20.2%
5,320.3
20.2%
5,773.8
20.2%
6,264.9
20.2%
6,736.1
20.2%
7,191.9
20.2%
7,624.4
20.2%
8,025.5
20.2%
8,387.2
20.2%
8,702.0
20.2%
8,963.0
20.2%
NOPAT
% effective tax rate
1,819.1
12.7%
2,258.9
13.2%
2,496.9
13.5%
3,350.3
16.3%
3,161.8
14.0%
4,233.5
17.3%
4,560.1
17.3%
4,948.7
17.3%
5,369.7
17.3%
5,773.5
17.3%
6,164.2
17.3%
6,534.9
17.3%
6,878.6
17.3%
7,188.6
17.3%
7,458.5
17.3%
7,682.2
17.3%
% of revenue
812.0
5.7%
990.0
5.8%
998.0
5.4%
1,028.0
5.0%
1,050.0
4.6%
1,231.4
5.0%
1,326.4
5.0%
1,439.4
5.0%
1,561.8
5.0%
1,679.3
5.0%
1,792.9
5.0%
1,900.7
5.0%
2,000.7
5.0%
2,090.9
5.0%
2,169.4
5.0%
2,234.5
5.0%
% of revenue
(487.0)
(3.4%)
(525.0)
(3.1%)
(588.0)
(3.2%)
(575.0)
(2.8%)
(755.0)
(3.3%)
(762.6)
(3.1%)
(821.4)
(3.1%)
(891.4)
(3.1%)
(967.2)
(3.1%)
(1,040.0)
(3.1%)
(1,110.3)
(3.1%)
(1,177.1)
(3.1%)
(1,239.0)
(3.1%)
(1,294.9)
(3.1%)
(1,343.5)
(3.1%)
(1,383.8)
(3.1%)
866.0
6.0%
279.0
1.6%
(732.0)
(4.0%)
(500.0)
(2.4%)
0.0
0.0%
(523.4)
(2.1%)
(563.8)
(2.1%)
(611.9)
(2.1%)
(663.9)
(2.1%)
(713.9)
(2.1%)
(762.2)
(2.1%)
(808.0)
(2.1%)
(850.5)
(2.1%)
(888.8)
(2.1%)
(922.2)
(2.1%)
(949.9)
(2.1%)
Free Cash Flow to Firm (FCFF)
% of revenue
3,010.1
21.0%
3,002.9
17.6%
2,174.9
11.8%
3,303.3
16.1%
3,456.8
15.3%
4,178.8
17.0%
4,501.2
17.0%
4,884.8
17.0%
5,300.3
17.0%
5,698.9
17.0%
6,084.6
17.0%
6,450.5
17.0%
6,789.8
17.0%
7,095.8
17.0%
7,362.2
17.0%
7,583.0
17.0%
% of FCFF used in calculation
78.1%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
Discount period
0.50
1.50
2.50
3.50
4.50
5.50
6.50
7.50
8.50
9.50
Discount factor
0.96
0.89
0.83
0.77
0.71
0.66
0.61
0.57
0.52
0.49
Discounted FCFF (DFCFF)
3,141.4
4,016.9
4,040.6
4,063.9
4,050.2
4,008.2
3,938.7
3,842.9
3,722.6
3,580.0

SYK DCF Value

DCF Value Calculation

as of Mar 21, 2025
Sum of DFCFF
% share of EV
38.4B
33.7%
Terminal Value (TV)
155.2B
Discounted TV
% share of EV
75.5B
66.3%
Total Debt
1,409.0M
Shares outstanding
381.0M
FX rate
1.0
17.3% overvalued

Equity Value Bridge

SYK Earnings Power Value and Enterprise Value

Annual
LTM
Enterprise Value Breakdown
EPV and MIVoG as % of EV

SYK Reverse DCF

Implied FCF growth
Implied Revenue growth

Reverse DCF Assumptions and Outputs

as of Dec 31, 2024
Long-Term growth rate
3.0%
FX rate
1.0
Last share price
360.1
Implied FCF growth 1-10Y
11.0%

Implied Free Cash Flow growth vs Historical average vs Industry growth

Competing with SYK Intrinsic Value

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Enterprise Value
Intrinsic Value
DCF Value
Relative value
Ben Graham Revised fair value
Peter Lynch fair value
Earnings Power Value (EPV), % of EV
Market-Implied Value of Growth (MIVoG), % of EV
Reverse DCF (implied FCF growth)
Reverse DCF (implied Revenue growth)
$141.4B
$150.6B
$305.8
17.6% overvalued
$306.8
17.0% overvalued
$304.8
17.9% overvalued
$527.5
42.2% undervalued
$302.1
18.6% overvalued
27.2%
72.8%
11.0%
11.9%
$218.8B
$225.8B
$187.7
48.6% undervalued
$216.2
71.0% undervalued
$159.1
26.0% undervalued
Negative
238.8% overvalued
Negative
175.8% overvalued
89.9%
10.1%
5.6%
5.7%
$148.2B
$159.0B
$37.4
62.9% overvalued
$18.2
82.0% overvalued
$56.6
43.8% overvalued
$144.8
43.8% undervalued
$76.6
23.9% overvalued
21.8%
78.2%
13.5%
15.2%
$115.8B
$134.5B
$122.4
35.5% undervalued
$90.6
0.0% overvalued
$154.2
70.7% undervalued
$293.9
225.4% undervalued
$160.1
77.2% undervalued
48.5%
51.5%
1.7%
1.8%
$41.6B
$38.3B
$56.4
20.0% overvalued
$43.1
39.0% overvalued
$69.6
1.2% overvalued
Negative
591.6% overvalued
Negative
474.1% overvalued
34.9%
65.1%
33.7%
28.0%
$29.5B
$29.4B
$40.2
45.6% overvalued
$27.7
63.0% overvalued
$52.7
28.6% overvalued
$62.1
15.9% overvalued
$46.2
37.4% overvalued
16.3%
83.7%
18.2%
18.5%
$23.6B
$29.3B
$72.8
185.6% undervalued
N/A
$72.8
185.6% undervalued
$162.5
537.4% undervalued
N/A
(204.2%)
304.2%
2.4%
14.1%
$22.4B
$28.1B
$185.6
67.6% undervalued
$150.1
36.0% undervalued
$221.1
99.7% undervalued
$254.8
130.1% undervalued
$187.3
69.2% undervalued
58.1%
41.9%
(0.5%)
(0.3%)
$21.7B
$23.8B
$204.3
7.3% overvalued
$117.2
47.0% overvalued
$291.4
32.2% undervalued
$588.4
167.0% undervalued
$298.0
35.2% undervalued
38.1%
61.9%
7.7%
9.1%
$18.8B
$18.0B
$107.4
60.0% overvalued
$67.7
75.0% overvalued
$147.1
45.2% overvalued
Negative
143.3% overvalued
Negative
112.9% overvalued
23.2%
76.8%
21.4%
24.6%
$12.5B
$12.2B
$153.5
54.2% overvalued
N/A
$153.5
54.2% overvalued
$113.9
66.0% overvalued
$104.3
68.8% overvalued
15.7%
84.3%
18.3%
17.9%

Intrinsic Valuation Tools

Wondering how to calculate intrinsic value of a stock? Use our intrinsic value tools to simplify complex valuation concepts and save time.

FAQ

What is the DCF value of Stryker Corporation (SYK)?

As of today, DCF Value of Stryker Corporation is $306.8, which is overvalued by 17.3%, compared to the current market share price of $371.1

How was the DCF Value calculated?

Step 1: Calculating Intrinsic Enterprise Value DCF Value was calculated by estimating Stryker Corporation future free cash flow and then discounting it, using a chosen discount rate to determine Intrinsic Enterprise Value of $0.0B Step 2: Balance Sheet Adjustments Intrinsic Equity Value is calculated by subtracting Balance Sheet items (Cash & Equivalents, Short-term investments and Total Debt) from previously calculated Intrinsic Enterprise Value. This Intrinsic Equity Value is then divided by the total number of outstanding shares of 0 to determine DCF Value of $306.8

What is the Relative value of Stryker Corporation (SYK)?

As of today, Relative Value of Stryker Corporation is $304.8, which is overvalued by 17.9%, compared to the current market share price of $371.1

How was the Relative Value calculated?

Relative Value was calculated by applying various valuation multiples (EV/Revenue, EV/EBITDA, P/E etc.) to Stryker Corporation financials to determine Relative Value of $304.8

What is Stryker Corporation (SYK) discount rate?

Stryker Corporation current Cost of Equity is 8.6%, while its WACC stands at 7.9%. Cost of Equity is used to value equity, while discounting free cash flow to equity holders (such as Net Income or Free Cash Flow to Equity). Weighted Average Cost of Capital (WACC) is used to value the entire firm, while discounting cash flows available to both debt and equity holders (NOPAT or Free Cash Flow to the Firm)

How is Cost of Equity for Stryker Corporation (SYK) calculated?

The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP). This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk. Cost of Equity = Risk-Free Rate + Beta x Effective Risk Premium (ERP) 8.6% = 4.3% + 1.0 x 4.6%

How is WACC for Stryker Corporation (SYK) calculated?

WACC, or Weighted Average Cost of Capital, is a calculation that reflects the average rate of return a company is expected to pay its security holders to finance its assets. It is a critical measure in financial analysis for valuing a company's entire operations. The WACC formula combines the costs of equity and debt, weighted by their respective proportions in the company's capital structure. WACC = Cost of Equity x Equity Weight in Total Capital + Cost of Debt x (1 - Effective Tax Rate) Debt Weight in Total Capital 7.9% = 8.6% x 8.8% + 0.0% x (1 - (3.4%)) x 91.2%